Point of Care. And Portable.
Diagnostics for Infectious Disease and Cancer Screening.
We are dedicated to building the first comfortable saliva-based test that uses proprietary DNA and RNA biomarkers and a low-cost, portable system to diagnose diseases like COVID-19 as accurately as today’s centralized, labor intensive PCR.
FlexBioTech is the leader in developing rapid, low cost diagnostics for infectious disease and cancer screening in low resource environments.
We are developing biomarker guided medical diagnostic tests used with a portable reader that can be easily and routinely be performed anywhere – at home, in the clinic or in the field.
We want to transform healthcare from reactive and hospital-centered to preventative, proactive and person-centered.
The robustness, portability and ease of use of our diagnostics enables decentralized and effective infectious disease management at scale.